Gastroenterology Practice Questions

Q: A 41-year-old male patient presented with recurrent episodes of bloody diarrhea for 5 years. Despite regular treatment with adequate doses of sulfasalazine, he has had several exacerbations of his disease and required several weeks of steroids for the control of flares. What should be the next line of treatment for him?

Azathioprine. ### Explanation The patient presents with chronic, relapsing **Ulcerative Colitis (UC)** that is **steroid-dependent**. He has failed maintenance therapy with 5-ASA (Sulfasalazine) and requires repeated courses of corticosteroids to control flares. [1] **1. Why Azathioprine is Correct:** In inflammatory bowel disease (IBD), when a patient cannot taper off steroids without a relapse or requires frequent steroid pulses, they are classified as "steroid-dependent." The standard next step in management is the introduction of **Thiopurines (Azathioprine or 6-Mercaptopurine)**. These are "steroid-sparing agents" used for the maintenance of remission in UC. [1] They take 3–6 months to reach peak efficacy, making them unsuitable for acute flares but ideal for long-term control in this scenario. **2. Why Other Options are Incorrect:** * **A. Methotrexate:** While used as a second-line immunomodulator in **Crohn’s Disease**, its efficacy in Ulcerative Colitis is not well-established and is generally not the first-choice steroid-sparing agent for UC. * **C. Cyclosporine:** This is a potent immunosuppressant used for **acute severe ulcerative colitis** (refractory to IV steroids) as "rescue therapy" to avoid emergency colectomy. It is not used for routine maintenance in a stable but steroid-dependent patient. * **D. Cyclophosphamide:** This drug has no established role in the standard management of Ulcerative Colitis due to its significant toxicity profile. **Clinical Pearls for NEET-PG:** * **Step-up Therapy:** 5-ASA → Steroids (for induction) → Thiopurines (for maintenance) → Biologics (Infliximab/Adalimumab) → Surgery. [1] * **Monitoring:** Before starting Azathioprine, check **TPMT (Thiopurine Methyltransferase)** activity to predict the risk of severe bone marrow suppression. * **Side Effects:** Monitor for pancreatitis, leucopenia, and increased risk of non-melanoma skin cancer/lymphoma.

Q: Which of the following is NOT a precipitating factor of hepatic encephalopathy in a patient with chronic liver disease?

Hyperkalemia. Hepatic Encephalopathy (HE) is a reversible neuropsychiatric syndrome caused by the accumulation of neurotoxins (primarily ammonia) in the brain due to liver failure or portosystemic shunting [1]. **Why Hyperkalemia is the Correct Answer:** **Hypokalemia**, not hyperkalemia, is a classic precipitant of HE. When potassium levels are low, the body attempts to conserve $K^+$ in the renal tubules by exchanging it for $H^+$ ions. This intracellular acidosis in renal cells stimulates the enzyme glutaminase, leading to increased **renal ammoniagenesis** (production of $NH_3$). Furthermore, hypokalemia-induced alkalosis shifts the equilibrium from ammonium ($NH_4^+$) to ammonia ($NH_3$), which easily crosses the blood-brain barrier. **Analysis of Incorrect Options:** * **TIPS:** This procedure creates a low-resistance tract between the portal and systemic circulation [1]. By bypassing the liver's detoxification process, neurotoxins reach the systemic circulation directly, making HE a common post-procedural complication. * **High Dietary Protein:** Protein breakdown by colonic bacteria produces ammonia [1]. A sudden large protein load (or GI bleed, which is essentially a protein load) increases ammonia production beyond the liver's capacity to clear it. * **Infection:** Sepsis and spontaneous bacterial peritonitis (SBP) increase tissue catabolism and impair renal function, both of which elevate blood ammonia levels and increase the permeability of the blood-brain barrier. **High-Yield Clinical Pearls for NEET-PG:** * **Most common precipitant:** Azotemia (often due to over-diuresis) and Infections. * **Electrolyte disturbances:** Hypokalemia, Hyponatremia, and Metabolic Alkalosis all precipitate HE. * **Drug of choice:** **Lactulose** (converts $NH_3$ to non-absorbable $NH_4^+$ and acts as an osmotic laxative). * **Second-line/Add-on:** **Rifaximin** (non-absorbable antibiotic that reduces ammonia-producing gut flora).

Q: Oral ulceration resembling aphthae are encountered in which of the following conditions?

Gluten enteropathy. **Explanation:** **1. Why Gluten Enteropathy is Correct:** Gluten enteropathy (Celiac Disease) is a common systemic cause of recurrent aphthous-like ulcers. These oral lesions often precede gastrointestinal symptoms. The underlying mechanism is two-fold: first, the **malabsorption** of essential nutrients (specifically Iron, Vitamin B12, and Folate) due to villous atrophy in the small intestine; and second, an **immunological cross-reactivity** where the oral mucosa becomes a target of the inflammatory process. In many patients, a gluten-free diet leads to the complete resolution of these ulcers. **2. Why the Other Options are Incorrect:** * **Chronic Smokers:** Interestingly, smoking is considered "protective" against aphthous ulcers. Nicotine stimulates the production of adrenal steroids and increases keratinization of the oral mucosa, making it less susceptible to ulceration. Ulcers often flare up *after* smoking cessation. * **Excess of B-complex vitamins:** It is the **deficiency** (specifically B1, B2, B6, and B12), not the excess, that causes oral manifestations like glossitis, cheilosis, and aphthous ulcers. * **Anti-malarial medication:** While some drugs (like NSAIDs or Nicorandil) cause oral ulcers, anti-malarials (e.g., Hydroxychloroquine) are actually sometimes used off-label to *treat* severe recurrent aphthous stomatitis due to their immunomodulatory effects. **Clinical Pearls for NEET-PG:** * **RAS (Recurrent Aphthous Stomatitis)** is also strongly associated with **Behçet’s Disease** (pustular/genital sores) and **IBD** (Crohn’s > UC). * **Dermatitis Herpetiformis** is the pathognomonic skin manifestation of Celiac disease. * **Screening Gold Standard:** IgA Anti-tissue Transglutaminase (tTG) antibodies.

Q: A 40-year-old male presents with hematemesis. On examination, his BP was 90/60 mmHg and heart rate was 120/min. Splenomegaly was also present. What is the most probable cause of his bleeding?

Portal hypertension. ### Explanation The clinical presentation of **hematemesis** associated with **splenomegaly** and signs of **hemodynamic instability** (hypotension and tachycardia) strongly points toward **Portal Hypertension**, most commonly due to liver cirrhosis or non-cirrhotic portal fibrosis [1]. **1. Why Portal Hypertension is correct:** In portal hypertension, the increased pressure in the portal venous system leads to the development of portosystemic collaterals [2]. The most clinically significant collaterals are **esophageal and gastric varices**, which are prone to rupture, causing massive, life-threatening hematemesis [2]. The presence of **splenomegaly** is a hallmark sign of portal hypertension, resulting from chronic passive congestion of the spleen (congestive splenomegaly) [1]. **2. Why the other options are incorrect:** * **Gastric and Duodenal Ulcers (Options B & C):** While Peptic Ulcer Disease (PUD) is the most common cause of upper GI bleeding overall, it does **not** cause splenomegaly [1]. The presence of an enlarged spleen specifically shifts the differential toward portal venous pathology. * **Drug-induced GI injury (Option D):** NSAIDs or steroids can cause erosive gastritis or ulcers leading to hematemesis, but like PUD, they do not account for the finding of splenomegaly [1]. **Clinical Pearls for NEET-PG:** * **Most common cause of Portal HTN in India:** Liver Cirrhosis (Alcoholic/Viral). * **Most common cause of massive hematemesis in children with splenomegaly:** Extrahepatic Portal Venous Obstruction (EHPVO). * **Management Priority:** In a patient with BP 90/60 and HR 120, the immediate priority is **hemodynamic stabilization** (IV fluids/blood) before diagnostic endoscopy [1]. * **Drug of choice for active variceal bleed:** Terlipressin or Octreotide. * **Definitive treatment for acute variceal bleed:** Endoscopic Variceal Ligation (EVL).

Q: Which of the following would be least likely to cause an ulcer in the distal esophagus?

Zenker's diverticulum. The correct answer is **Zenker’s diverticulum**. The key to this question lies in the **anatomical location**. Zenker’s diverticulum is a pulsion diverticulum occurring at the **Killian’s dehiscence** (between the thyropharyngeus and cricopharyngeus muscles). This is located in the **proximal (upper) esophagus** or hypopharynx [1]. Therefore, it is anatomically impossible for it to cause an ulcer in the **distal esophagus**. **Analysis of Options:** * **HSV (Herpes Simplex Virus):** Viral esophagitis typically affects the squamous epithelium of the mid-to-distal esophagus. HSV characteristically causes small, "punched-out" ulcers. * **Achalasia Cardia:** While primarily a motility disorder, stasis of food and saliva in the dilated distal esophagus can lead to "stasis esophagitis" and subsequent mucosal ulceration [1]. * **Severe Reflux Esophagitis (GERD):** This is the most common cause of distal esophageal ulcers [2]. Chronic exposure to gastric acid and pepsin leads to mucosal erosion, typically just above the gastroesophageal junction. **NEET-PG High-Yield Pearls:** 1. **Zenker’s Diverticulum:** Presents with halitosis, regurgitation of undigested food, and a neck mass that "gurgles." It is a *false* diverticulum (only mucosa and submucosa herniate) [1]. 2. **Drug-Induced Esophagitis:** Often occurs at the level of the **arch of the aorta** (mid-esophagus) due to anatomical narrowing. Common culprits: Tetracyclines, NSAIDs, and Bisphosphonates. 3. **Cytomegalovirus (CMV):** Unlike the "punched-out" ulcers of HSV, CMV typically causes **large, solitary, linear ulcers** in the distal esophagus, especially in immunocompromised patients.

Q: Which of the following is NOT a treatment for hepatic encephalopathy?

High protein diet. Explanation: Hepatic Encephalopathy (HE) is a reversible neuropsychiatric syndrome caused by liver failure and portosystemic shunting [1]. The primary pathophysiology involves the accumulation of neurotoxic substances, most notably ammonia ($NH_3$), which crosses the blood-brain barrier [1]. Why Option A is the correct answer: Ammonia is a byproduct of protein metabolism by intestinal bacteria [1]. Historically, protein restriction was practiced; however, modern guidelines emphasize that high protein intake (1.2–1.5 g/kg/day) is essential to prevent muscle wasting (sarcopenia), which actually worsens HE because muscle helps detoxify ammonia [2]. Therefore, a "high protein diet" is a nutritional requirement, but protein restriction (not high protein) was the traditional (though now largely obsolete) "treatment" logic. In the context of this question, a high protein diet does not treat an acute episode; rather, it is the management of the underlying nutritional state. Why the other options are incorrect: * Lactulose (Option B): The first-line treatment. It is a non-absorbable disaccharide that acidifies the colon, converting $NH_3$ to non-absorbable $NH_4^+$ (ammonia trapping) and acts as an osmotic laxative. * Oral Neomycin (Option C): An antibiotic that reduces ammonia-producing bacteria in the gut. (Rifaximin is now preferred due to lower toxicity). * Enema (Option D): Used to rapidly clear the bowel of nitrogenous waste and blood (a common precipitant), reducing ammonia absorption. NEET-PG High-Yield Pearls: * Drug of Choice: Lactulose (for acute and maintenance). * Best Add-on Therapy: Rifaximin (reduces recurrence). * Most common precipitant: Infections (SBP), GI bleed, dehydration, or constipation. * Flumazenil: May be used transiently if benzodiazepine overdose is suspected as a trigger.

Question 1

A patient with a known history of pancreatitis presents on Day 4 with breathlessness and basal crepitations. What is the most likely diagnosis?

Accepted Answer

Acute respiratory distress syndrome (ARDS)

Answer

Atelectasis

Answer

Pleural effusions

Answer

Aspiration pneumonia

Question 2

A 41-year-old male patient presented with recurrent episodes of bloody diarrhea for 5 years. Despite regular treatment with adequate doses of sulfasalazine, he has had several exacerbations of his disease and required several weeks of steroids for the control of flares. What should be the next line of treatment for him?

Accepted Answer

Azathioprine

Answer

Methotrexate

Answer

Cyclosporine

Answer

Cyclophosphamide

Question 3

Which of the following is NOT a precipitating factor of hepatic encephalopathy in a patient with chronic liver disease?

Accepted Answer

Hyperkalemia

Answer

TIPS (Transjugular Intrahepatic Portosystemic Shunt)

Answer

High dietary protein load

Answer

Infection

Question 4

Oral ulceration resembling aphthae are encountered in which of the following conditions?

Accepted Answer

Gluten enteropathy

Answer

Chronic smokers

Answer

Excess of B-complex vitamins

Answer

Anti-malarial medication

Question 5

A 40-year-old male presents with hematemesis. On examination, his BP was 90/60 mmHg and heart rate was 120/min. Splenomegaly was also present. What is the most probable cause of his bleeding?

Accepted Answer

Portal hypertension

Answer

Gastric ulcer

Answer

Duodenal ulcer

Answer

Drug-induced GI injury

Question 6

A 56-year-old man presents with jaundice and mild fatigue over the past 2 months. He is not on any medications and has no significant past medical history. Physical examination reveals scleral icterus. Laboratory findings include: SGOT: 0.58 microkat/L, SGPT: 0.58 microkat/L, Total bilirubin: 91.7 micromol/L, Direct bilirubin: 85.5 micromol/L, and Alkaline phosphatase: 12 microkat/L. What is the next appropriate diagnostic step?

Accepted Answer

Ultrasound

Answer

Liver biopsy

Answer

Review of peripheral blood smear

Answer

Endoscopic retrograde cholangiopancreatography (ERCP)

Question 7

A patient with chronic liver disease presents with ascites and has no history of bleeding varices. The patient develops hematemesis and melena. What is the next step in management?

Accepted Answer

Fresh frozen plasma transfusion

Answer

Injectable vitamin K

Answer

Injectable Tranexamic acid

Answer

Platelet transfusion

Question 8

Which of the following would be least likely to cause an ulcer in the distal esophagus?

Accepted Answer

Zenker's diverticulum

Answer

HSV

Answer

Achalasia cardia

Answer

Severe reflux esophagitis

Question 9

A 23-year-old man has noted a yellow color to his sclerae for the past 2 weeks. On physical examination, he has generalized jaundice. He has the physique of a bodybuilder. Laboratory studies show serum total bilirubin, 5.6 mg/dL; ALT, 117 U/L; AST, 103 U/L; alkaline phosphatase, 148 U/L; albumin, 5.5 g/dL; and total protein, 7.9 g/dL. Which of the following substances is he most likely to be using?

Accepted Answer

Anabolic steroid

Answer

Acetaminophen

Answer

Chlorpromazine

Answer

Ethyl alcohol

Question 10

Which of the following is NOT a treatment for hepatic encephalopathy?

Accepted Answer

High protein diet

Answer

Lactulose

Answer

Oral neomycin

Answer

Enema

Gastroenterology — MCQs

Gastroenterology — MCQs

On this page

Practice by Chapter

Want unlimited practice?